This inventor holds 1 USPTO granted patent. Top assignee: Ark Therapeutics Limited. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Markku Kulomaa: Innovator in Biotin-Binding Receptors
Introduction
Markku Kulomaa is a notable inventor based in Jyväskylä, Finland. He has made significant contributions to the field of biotechnology, particularly in the development of novel proteins that interact with biotinylated molecules. His work has implications for various applications in medical and research settings.
Latest Patents
Kulomaa holds a patent titled "Nucleic acids encoding biotin-binding receptors." This invention pertains to a novel transmembrane protein capable of binding to biotinylated molecules. The protein comprises a cytoplasmic domain, a membrane-spanning domain, and an extracellular domain, wherein the extracellular domain exhibits biotin-binding activity. He has 1 patent to his name.
Career Highlights
Markku Kulomaa is associated with Ark Therapeutics Limited, where he continues to advance his research and innovations. His work focuses on the intersection of biotechnology and medicine, contributing to the development of new therapeutic strategies.
Collaborations
Kulomaa has collaborated with notable colleagues in his field, including Kari Juhani Airenne and Seppo Yla-Herttuala. These collaborations have enhanced the scope and impact of his research.
Conclusion
Markku Kulomaa's innovative work in biotin-binding receptors showcases his commitment to advancing biotechnology. His contributions are paving the way for future developments in the field.